The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(4-(5-chloropyridin-2-yl)piperazin-1-yl)((1S,2S,4R)-4-((R)-1-phenylethylamino)-2-(thiophen-3-yl)cyclohexyl)methanone ID: ALA1940371
PubChem CID: 57400009
Max Phase: Preclinical
Molecular Formula: C28H33ClN4OS
Molecular Weight: 509.12
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C[C@@H](N[C@@H]1CC[C@H](C(=O)N2CCN(c3ccc(Cl)cn3)CC2)[C@@H](c2ccsc2)C1)c1ccccc1
Standard InChI: InChI=1S/C28H33ClN4OS/c1-20(21-5-3-2-4-6-21)31-24-8-9-25(26(17-24)22-11-16-35-19-22)28(34)33-14-12-32(13-15-33)27-10-7-23(29)18-30-27/h2-7,10-11,16,18-20,24-26,31H,8-9,12-15,17H2,1H3/t20-,24-,25+,26-/m1/s1
Standard InChI Key: LEHHYQLIWLBROC-YEHREXKJSA-N
Molfile:
RDKit 2D
35 39 0 0 0 0 0 0 0 0999 V2000
31.6083 -6.2417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6083 -7.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3204 -7.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0324 -7.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0324 -6.2417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3204 -5.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7480 -5.8313 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.4613 -6.2459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1770 -5.8354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4589 -7.0708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8906 -6.2557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6057 -5.8460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6086 -5.0201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8903 -4.6057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1781 -5.0178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3199 -8.3003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6525 -8.7852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9075 -9.5698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7325 -9.5698 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
32.9873 -8.7852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8945 -7.4802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1794 -7.0687 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.8957 -8.3052 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.1759 -6.2405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4649 -5.8291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7486 -6.2391 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.7478 -7.0651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4633 -7.4810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0341 -5.8208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0374 -4.9947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3247 -4.5806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6084 -4.9915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6160 -5.8208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3223 -6.2311 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.8926 -4.5813 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 6 1 0
8 9 1 0
2 3 1 0
17 18 2 0
18 19 1 0
19 20 1 0
20 16 2 0
3 16 1 6
8 10 1 1
2 21 1 1
3 4 1 0
21 22 1 0
9 11 2 0
21 23 2 0
22 24 1 0
4 5 1 0
11 12 1 0
5 6 1 0
12 13 2 0
22 28 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
13 14 1 0
5 7 1 1
29 30 2 0
14 15 2 0
30 31 1 0
15 9 1 0
31 32 2 0
16 17 1 0
32 33 1 0
1 2 1 0
33 34 2 0
34 29 1 0
26 29 1 0
7 8 1 0
32 35 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 509.12Molecular Weight (Monoisotopic): 508.2064AlogP: 5.75#Rotatable Bonds: 6Polar Surface Area: 48.47Molecular Species: BASEHBA: 5HBD: 1#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 9.60CX LogP: 5.53CX LogD: 3.36Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.46Np Likeness Score: -1.70
References 1. Anthony Romero F, Hastings NB, Moningka R, Guo Z, Wang M, Di Salvo J, Lei Y, Trusca D, Deng Q, Tong V, Terebetski JL, Ball RG, Ujjainwalla F.. (2012) The discovery of potent antagonists of NPBWR1 (GPR7)., 22 (2): [PMID:22197390 ] [10.1016/j.bmcl.2011.11.126 ]